Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Alkermes (ALKS) EBITDA (2016 - 2025)

Alkermes (ALKS) has disclosed EBITDA for 16 consecutive years, with $48.3 million as the latest value for Q4 2025.

  • Quarterly EBITDA fell 66.48% to $48.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $241.5 million through Dec 2025, down 34.4% year-over-year, with the annual reading at $241.5 million for FY2025, 34.4% down from the prior year.
  • EBITDA for Q4 2025 was $48.3 million at Alkermes, down from $83.1 million in the prior quarter.
  • The five-year high for EBITDA was $237.8 million in Q2 2023, with the low at -$66.3 million in Q3 2022.
  • Average EBITDA over 5 years is $37.9 million, with a median of $29.7 million recorded in 2024.
  • The sharpest move saw EBITDA plummeted 6840.9% in 2022, then soared 834.04% in 2023.
  • Over 5 years, EBITDA stood at -$379000.0 in 2021, then tumbled by 6840.9% to -$26.3 million in 2022, then surged by 539.99% to $115.7 million in 2023, then increased by 24.51% to $144.1 million in 2024, then crashed by 66.48% to $48.3 million in 2025.
  • According to Business Quant data, EBITDA over the past three periods came in at $48.3 million, $83.1 million, and $87.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.